File:Strategy for the development of engineered live bacterial therapeutic clinical candidates.pdf
From WikiMD's WELLNESSPEDIA
Size of this JPG preview of this PDF file: 514 × 599 pixels.
Original file (675 × 787 pixels, file size: 396 KB, MIME type: application/pdf)
Summary[edit]
| Summary | |
|---|---|
| Description | Schematic representation of a workflow for developing clinical candidate-quality engineered strains. The development workflow should incorporate technologies for optimizing strain potency, as well as predictive in vitro and in vivo assays, as well quantitative pharmacology models, to maximize translational potential for patient populations.[1] |
| Source | Wikimedia Commons file page |
| Author | Mark R. Charbonneau, Vincent M. Isabella, Ning Li & Caroline B. Kurtz |
| Permission | See original Commons license details. |
Licensing[edit]
Creative Commons Attribution 4.0 International (CC BY 4.0)
This file is licensed under the Creative Commons Attribution 4.0 International license.
You may share and adapt the material provided appropriate attribution is given.
Official license: CC BY 4.0
License page: CC BY 4.0
Original attribution and file history: Wikimedia Commons
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 03:23, 5 June 2026 |  | 675 × 787 (396 KB) | Maintenance script (talk | contribs) | == Summary == Importing file |
You cannot overwrite this file.
File usage
The following 2 pages use this file:
